Related Experiment Video
Updated: Jun 23, 2026

04:38
A Murine Tail Lymphedema Model
Published on: February 10, 2021
Vulval lymphoedema following pulmonary tuberculosis
A Talwar1, N Puri, H P S Sandhu
1Department of Surgery & Dermatology, GGS Medical College & Hospital, Faridkot 151203, Punjab, India. neerjaashu@rediffmail.com
International Journal of STD & AIDS
|May 20, 2009
Summary
Acquired vulvar lymphoedema can result from impaired lymph flow. This case highlights vulvar lymphoedema in a woman after pulmonary tuberculosis treatment, with biopsy showing skin changes and dilated lymphatics.
Area of Science:
- Gynecology
- Dermatology
- Infectious Diseases
Background:
- Acquired lymphoedema of the vulva is a rare condition.
- It is typically caused by impaired lymphatic drainage.
- Pulmonary tuberculosis is a potential, though uncommon, cause of secondary lymphoedema.
Observation:
- A 35-year-old woman presented with vulvar lymphoedema.
- The condition developed four years after completing treatment for pulmonary tuberculosis.
- Histopathological examination of perianal swellings revealed hyperkeratosis, acanthosis, and dilated lymphatic spaces.
Findings:
- The case demonstrates a link between a history of pulmonary tuberculosis and the development of acquired vulvar lymphoedema.
- Biopsy findings are consistent with chronic lymphedema and secondary skin changes.
Implications:
- This case expands the understanding of potential etiologies for acquired vulvar lymphoedema.
- Further research may be warranted to explore the mechanisms linking tuberculosis and lymphatic dysfunction.
- Clinicians should consider a history of tuberculosis in the differential diagnosis of vulvar lymphoedema.
Related Concept Videos
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

